Asthma Drug Montelukast (Singulair) Can Block Crucial COVID Protein, Reducing Viral Replication - SciTechDaily

An oral medication used to treat asthma and allergies can bind to and block a crucial protein produced by the SARS-CoV-2 virus, and reduce viral replication in human immune cells, according to a new study by researchers at the Indian Institute of Science (IIS…

ByIndian Institute of Science (IISc)April 27, 2022 Targeting Nsp1 with montelukast (Singulair) helps prevent shutdown of host protein synthesis. Credit: Mohammad Afsar An oral medication used to tr… [+4240 chars]

full article...